The role of incretins and incretin-based drugs in autoimmune diseases

Shabnam Radbakhsh, Stephen L. Atkin, Luis E. Simental-Mendia, Amirhossein Sahebkar

Research output: Contribution to journalReview article

Abstract

Incretin hormones, including glucagon-like peptide (GLP)-1, GLP-2 and glucose-dependent insulinotropic polypeptide (GIP), are gastrointestinal peptides secreted from enteroendocrine cells. These hormones play significant roles in many physiological processes via binding to G-protein coupled receptors (GPCRs) on different organs and tissues; one of them is the immunomodulatory effect on the immune system and its molecular components such as cytokines and chemokines. Anti-inflammatory effects of incretins and dependent molecules involving long-acting analogs and DPP4 inhibitors through regulation of T and B cell activation may attenuate autoimmune diseases caused by immune system disorders in mistakenly recognizing self as the foreign agent. In this review, we investigate incretin effects on the immune system response and the potential benefits of incretin-based therapy for treating autoimmune diseases.

Original languageEnglish
Article number107845
JournalInternational Immunopharmacology
Volume98
DOIs
Publication statusPublished - Sep 2021

Fingerprint

Dive into the research topics of 'The role of incretins and incretin-based drugs in autoimmune diseases'. Together they form a unique fingerprint.

Cite this